Obesity and Dyslipidemia



The prevalence of obesity among school age children is increasing exponentially over the past 3 decades. Dyslipidemia is defined as: Total cholesterol (TC) >200 mg/dL HDL-C <45 mg/dL LDL-C >130 mg/dL Triglycerides >150 mg/dL in adolescents and >130 mg/dL in children Early screening (between 2 and 8 years of age) should be done in all of the following high-risk groups: Family history of early coronary artery disease or stroke Familial dyslipidemia BMI >85‰ History of Kawasaki disease Active kidney disease or who have received a kidney transplant After heart transplant Type I or II diabetes Congenital heart disease Cancer treatment survivors Pharmacotherapy should be used in patients greater than 8 years of age with total cholesterol persistently higher than 190 mg/dL despite changes in lifestyle and diet. Pharmacotherapy includes agents such as: Bile acid sequestrants Niacin Fish oil or omega-3 fatty acids HMG Co-A reductase inhibitors: such as Statins Cholesterol absorption inhibitors


Obstructive Sleep Apnea Kawasaki Disease Slip Capital Femoral Epiphysis Idiopathic Intracranial Hypertension Familial Hypercholesterolemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Pediatric CardiologyJohn Hopkins Medical InstitutesBaltimoreUSA

Personalised recommendations